You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: Zymeron Corporation Topic: CBD181004
Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: ADVANCED MECHANICAL SYSTEMS TECHNOLOGY, Topic: CBD06101
This proposal presents a Phase I SBIR project to develop a high precision, low disperse rate powder disseminator for the US Army. In the development of the sensitive detecting agent, we need to release a precise amount of C&B agents in the controlled detection experiments. However, such a technology does not exist at the present time. After examining existing technologies, we believe that the r ...SBIR Phase I 2006 Department of DefenseOffice for Chemical and Biological Defense